MAP Pharmaceuticals Announces Results From LEVADEX Pharmacokinetics Trial In Smokers
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic …

Completion Of Phase I Diabetes Trial Announced By Mass. General Hospital, Iacocca Foundation
Massachusetts General Hospital (MGH) and the Iacocca Foundation have announced the completion of the Phase I BCG clinical trial in type 1 diabetes, as well as the submission of all safety reports to the U.S. Food and Drug Administration (FDA) and the MGH data safety monitoring boards. Plans for the Phase II clinical study, which will continue the investigation of bacillus Calmette-Guerin (BCG …

Sitagliptin Helps Poorly Controlled Patients With Type 1 Diabetes: A Pilot Trial
ORLANDO – The dipeptidyl peptidase (DPP-4) inhibitor sitagliptin seems to confer multiple benefits in type 1 diabetics with suboptimal glycemic control, according to early results released at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA). In a pilot study that included 20 type 1 patients, four weeks’ treatment with sitagliptin led to decreased hemoglobin (Hb)A1c …

Prosecution rests in Wone trial; judge to rule Thursday on dismissing charges
Prosecutors in the Robert Wone conspiracy trial rested their case Wednesday after presenting more than 30 witnesses and hundreds of exhibits over nearly four weeks that focused on something they were not even obligated to prove: who stabbed Wone to death. Murder of Robert Eric Wone – Murder – Law – Radio Free Asia – Services